About teqcool
TEQCool AB is a medical technology company based in Lund, Sweden. TEQCool develops a unique, patented solution for selectively cooling the brain of patients with brain-injury suffering from neurogenic fever.
The intended therapy is based on many years of research and development at Lund University, pre-clinical and clinical studies as well as technical development by TEQCool’s engineers.
our VISION
OUR VISION
Unique market opportunity
The global market for therapeutic temperature management is estimated to exceed 10 billion SEK per year.
The primary objective of temperature control is to preserve the patient’s neurogenic function. Existing systems cool the body in various ways and only secondarily the brain. TEQCool’s unique solution directly cools the brain via the nasal cavities. This selective and rapid brain cooling has the potential to transforming the temperature control market and establish a new treatment standard.
IR & dokument
Want to get more news about TEQCool?
Follow us on LinkedIn!
TEQCool AB
Arkivgatan 1d
SE-223 59 Lund
info(@)teqcool.com